UNSPSC 51351631: Estrone glucuronide

This classification denotes an estrogen with the molecular formula C24H30O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 933Q277TO2, chemically known as .beta.-d-glucopyranosiduronic acid, 17-oxoestra-1,3,5(10)-trien-3-yl, but more generally known as estrone glucuronide, which bears US NIH Compound Identifier 115255. European Medicines Agency schedules estrone glucuronide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07251MIG.

Most nations, for tariff purposes, schedule estrone glucuronide under HS 29372300. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CCC2=O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O.

UNSPSC 51351631 Estrone glucuronide is a Commodity code representing a single pharmaceutical active ingredient, but recent state and local procurement activity under this code is minimal. The single recent opportunity shows that state and local buyers classify broader pharmaceutical procurement under this code rather than purchasing estrone glucuronide as a discrete line item. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota and Oregon. The procurement encompasses hundreds of pharmaceutical products sourced through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencara, Cardinal Health, and Morris & Dickson Co.) and requires vendors to supply products meeting FDA requirements, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) compliance, with pricing evaluated on fixed-price, net-price, or WAC-minus formats.

The MMCAP RFP due March 26, 2026 represents the primary visible state and local contracting activity under this code. MMCAP is a multi-state cooperative purchasing vehicle administering contracts across member agencies in Minnesota and Oregon, making it a high-volume buyer for generic pharmaceutical distribution. Vendors responding must establish relationships with at least two of the three authorized wholesalers, maintain $5 million commercial general liability coverage, and accept a 3 percent administrative fee and performance penalties ranging from $200 to $1,500 per violation. The contract term runs two years from the July 1, 2026 effective date for new responders, with optional extensions at MMCAP's discretion, while incumbents' amendments extend through June 30, 2028. No specific dollar values, awards, or business set-asides are disclosed in the available documentation.